25 Paid Clinical Research Studies in Indianapolis, Indiana

Filtered for protocols that accept healthy volunteers or mention compensation. Always confirm stipend details and screening with the study coordinator.

Phase2

Pembrolizumab Plus Olaparib in LA-HNSCC

The purpose of this research study is to evaluate the effectiveness of using a combination of pembrolizumab and olaparib when given before and after standard chemoradiation therapy

๐Ÿ“ Indiana University Simon Comprehensive Cancer Center โ€” Indianapolis, Indiana

๐Ÿ’ต In the induction phase, participants will receive one infusion of pembrolizumab and will take olaparib tablets for a tot

View Study & Checklist โž”
Phase2

Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

Children and adults diagnosed with high-risk neuroblastoma patients with primary refractory disease or incomplete response to salvage treatment in bone and/or bone marrow will be t

๐Ÿ“ Riley Hospital for Children โ€” Indianapolis, Indiana

๐Ÿ’ต Naxitamab, also known as hu3F8 is a humanised monoclonal antibody targeting GD2 Each patient will receive treatment for

View Study & Checklist โž”
Observational / Diagnostic

Integrative Medicine in Pain Management in Sickle Cell Disease

The proposed research is to determine the clinical efficacy and neurobiological mechanisms of acupuncture analgesia in patients with sickle cell disease.

๐Ÿ“ Indiana University School of Medicine โ€” Indianapolis, Indiana

๐Ÿ’ต During the study visits: 1) Subjects will be randomized to 10 sessions with either traditional acupuncture (very fine ac

View Study & Checklist โž”
Phase2

Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer

The purpose of this research study is to test the safety of Niraparib and dostarlimab as a combination treatment and see what effects (good and bad) this combination treatment has

๐Ÿ“ Melvin and Bren Simon Comprehensive Cancer Center โ€” Indianapolis, Indiana

๐Ÿ’ต If found eligible, the patient will receive treatment with Niraparib daily and dostarlimab by vein every three weeks for

View Study & Checklist โž”
Phase2

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

This is a phase 2 study of gemcitabine, cisplatin, zimberelimab (AB122) and quemliclustat (AB680) in subjects with untreated advanced biliary tract cancers (BTC). The study will in

๐Ÿ“ Indiana University Melvin and Bren Simon Comprehensive Cancer Center โ€” Indianapolis, Indiana

๐Ÿ’ต Participants will receive 4 cycles of combination therapy as described.

View Study & Checklist โž”
Observational / Diagnostic

Finding Immune Nascent Type 1 Diabetes

The goal of this clinical trial is to understand how many individuals who previously participated in the Indiana Biobank will return a type 1 diabetes home screening kit based upon

๐Ÿ“ Indiana University School of Medicine โ€” Indianapolis, Indiana

View Study & Checklist โž”
Phase2

Study of Resmetirom in Children and Adolescents With MASH

This study will evaluate the safety, pharmacokinetics (how the body absorbs, distributes, metabolizes, and eliminates the drug), and pharmacodynamics (how the drug affects the body

๐Ÿ“ Riley Hospital for Children at IU Health โ€” Indianapolis, Indiana

๐Ÿ’ต Participants will receive oral resmetirom once daily for approximately 14 days at one of several dose levels.

View Study & Checklist โž”
Observational / Diagnostic

SPARK Healthy Sleep

SPARK-Healthy Sleep is a digital mental health intervention designed to help college students who may be at risk for psychosis and experience sleep problems. About 1 in 4 college s

๐Ÿ“ Indiana University โ€” Indianapolis, Indiana

View Study & Checklist โž”